Ricerca shells out $45M for MDS' early-stage ops

MDS Pharma Services says that Ricerca Biosciences is buying its discovery and preclinical services business for $45 million. The price includes a $25 million note, $20 million in cash and a minority equity interest. Ricerca provides early-stage CRO work. The operations include clinics and labs in Bothell, Wash., Lyon, France and Taipei. MDS says it will close its early-stage facility in Montreal. About 275 MDS jobs will be lost as part of the sale and plant closing. MDS release

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.